On Friday, Ascendis Pharma A/S ADR (NASDAQ: ASND) opened higher 5.85% from the last session, before settling in for the closing price of $122.64. Price fluctuations for ASND have ranged from $90.13 to $161.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 182.00% over the last five years. Company’s average yearly earnings per share was noted 15.22% at the time writing. With a float of $59.25 million, this company’s outstanding shares have now reached $59.76 million.
In terms of profitability, gross margin is 84.82%, operating margin of -96.44%, and the pretax margin is -127.34%.
Ascendis Pharma A/S ADR (ASND) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ascendis Pharma A/S ADR is 0.86%, while institutional ownership is 105.08%. The most recent insider transaction that took place on Nov 19 ’24, was worth 2,382,402.
Ascendis Pharma A/S ADR (ASND) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.54 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.76) by 0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.10% during the next five years compared to -19.87% drop over the previous five years of trading.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Trading Performance Indicators
Check out the current performance indicators for Ascendis Pharma A/S ADR (ASND). In the past quarter, the stock posted a quick ratio of 0.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.10, a number that is poised to hit -1.35 in the next quarter and is forecasted to reach -3.79 in one year’s time.
Technical Analysis of Ascendis Pharma A/S ADR (ASND)
Analysing the last 5-days average volume posted by the [Ascendis Pharma A/S ADR, ASND], we can find that recorded value of 0.51 million was better than the volume posted last year of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 50.57%. Additionally, its Average True Range was 5.29.
During the past 100 days, Ascendis Pharma A/S ADR’s (ASND) raw stochastic average was set at 42.12%, which indicates a significant decrease from 78.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.03% in the past 14 days, which was lower than the 45.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $133.21, while its 200-day Moving Average is $136.71. Now, the first resistance to watch is $132.51. This is followed by the second major resistance level at $135.21. The third major resistance level sits at $140.14. If the price goes on to break the first support level at $124.88, it is likely to go to the next support level at $119.94. Should the price break the second support level, the third support level stands at $117.24.
Ascendis Pharma A/S ADR (NASDAQ: ASND) Key Stats
There are currently 60,642K shares outstanding in the company with a market cap of 7.76 billion. Presently, the company’s annual sales total 288,670 K according to its annual income of -521,070 K. Last quarter, the company’s sales amounted to 63,590 K and its income totaled -109,080 K.
